Safety and Efficacy of "Immuncell-LC" in TACE Therapy
NCT02856815
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Carcinoma, Hepatocellular
Interventions
BIOLOGICAL:
Immuncell-LC
Sponsor
GC Cell Corporation